#StomachMicrobiome How does the performance of different microbiome analysis platforms impacts the results of mucosal microbiome signatures? ▶️Mucosal tissue ▶️Gastric Cancer vs. Controls ▶️H.pylori+ vs. H.pylori- ▶️5 independent groups 👉Different microbiome analysis

#EAGEN Postgraduate Course ▶️Dilemmas and Controversies in Digestive Diseases Nis, Serbia, 14th March 2025 👉Join us for a face-to-face meeting! eagen.org

#WhatsNewOnFMT #FMTinUC Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 👉Addresses gaps and uncertainties identified in previous FMT research to help standardise methods and protocols for treating UC in the

Someone at publisher didn't like the AGA's recommendations on H. pylori screening for gastric cancer prevention? 🤣

#EAGEN Postgraduate Course ▶️Dilemmas and Controversies in Digestive Diseases Nis, Serbia, 14-16th March 2025 👉Join us for a face-to-face meeting! eagen.org

#EAGENwebinar Immunotherapy in Digestive Cancers: Where are we today? 1 April 2025 17:30-18:45 CET Join 👇us02web.zoom.us/webinar/regist…

#WhatsNewOnFMT #CDI ❓Real-world efficacy of FMT for 1 and 2 CDI 📜n=467 multicentre study from Denmark 56% severe CDI 36% antibiotic-refractory CDI 19 fulminant CDI ✅Overall cure rate 79% ✅90-day mortality: 10% cghjournal.org/article/S1542-…

#WhatsNew on Management of precancerous conditions and early neoplasia of the stomach #MAPS3 ✅Fully updated and revised multidisciplinary #Guideline! ESGE #EHMSG EAGEN 👉esge.com/management-of-…

When #ERCP is performed in patients with biliary stenosis treated with stents - the stents are removed, replaced and discarded, but... ✅ stents preserve bile and sloughed cells, including #microRNA, suggesting it as a potential biomarker for biliary tract disease. Our

Does #endoscopy screening impact upper GI #cancer mortality? ✅YES (in high risk situations/areas) n= 234 635 participants (age ~52y) Deaths in #highrisk area Endoscopy: 480 vs. Controls: 545 Deaths in non-high risk area Endoscopy: 146 vs. Controls 149

Are you a basic scientist interested in pathogenesis in digestive diseases? Be part of the DDM Summit, a basic research initiative during the #UEGweek in October 2025! Share your research! Submit your abstract! ueg.eu/week/programme… my_UEG EAGEN EurFMT

#Olaparib considered a valuable option in patients with BRCA-mutation ovarian cancer ❗️disappointing final Overall Survival results from SOLO3 trial 👉Very valuable data for molecular tumour boards #MolecularOncology #PrecisionMedicine ascopubs.org/doi/10.1200/JC…

Interested in scientific advances related to the #microbiota in the upper GI tract? Join the Sino-German Summer Workshop on Microbiota in Upper GI Tract and Disease 25-26 July 2025 Technical University of Munich & Virtual 👉mih.mh.tum.de/de/summer-work…

#LifeInPlastic Nanoplastics are accumulating in the human brain—and their levels are rising. Why—and what are the consequences? rdcu.be/eiUYY

EAGEN (Europäische Gesellschaft für Gastroenterologie, Endoskopie und Ernährung) lädt in Zusammenarbeit mit Juvise Pharmaceuticals herzlich zu einem #Webinar ein: 📢Thema: Aktuelles Management von Helicobacter pylori-Infektionen 27. Mai 2025 um 17:00 Uhr Sprache: Deutsch

EAGEN (Europäische Gesellschaft für Gastroenterologie, Endoskopie und Ernährung) lädt herzlich zum #Webinar ein: 📢Thema: Aktuelles Management von Helicobacter pylori-Infektionen 27. Mai 2025 um 17:00 Uhr Sprache: Deutsch Registrierung 👇 us02web.zoom.us/webinar/regist…

What is the difference between probiotics and live biotherapeutic products (LBPs)? #Probiotics: ✅Live microorganisms which when administered in adequate amounts confer a ✅health benefit on the host. Live Biotherapeutic Products (#LBPs): A biological product that: (1)

#Cancer and #PhysicalExercise ✅Structured exercise program after adjuvant chemotherapy resulted in significantly longer disease-free survival and overall survival in CRC patients ❓Could an exercise program reduce the need for adjuvant chemotherapy in patients at "low risk"?